Showing results (1451-1460 of 2,996) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|June 15, 2021
The Current Role of Platelet Function Testing in Clinical PracticeGeorge A Mason, David J RabboliniSeminars in Thrombosis and Hemostasis|June 15, 2021
Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological MechanismsAdriana Inés Woods, Juvenal Paiva, Débora Marina Primrose, et al.Seminars in Thrombosis and Hemostasis|June 21, 2021
Thrombin: A Pivotal Player in Hemostasis and BeyondJulie Brogaard Larsen, Anne-Mette HvasSeminars in Thrombosis and Hemostasis|January 5, 2023
The Future of Laboratory-Developed Tests in Hemostasis LaboratoriesChris Gardiner, Marión Echenagucia, Robert C GosselinSeminars in Thrombosis and Hemostasis|June 23, 2022
Platelet Activation and Thrombosis in COVID-19Toshiaki Iba, Hideo Wada, Jerrold H LevySeminars in Thrombosis and Hemostasis|July 8, 2022
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian ExperienceEmmanuel J Favaloro, Elysse Dean, Sandya ArunachalamSeminars in Thrombosis and Hemostasis|July 8, 2022
A Review of Autoimmune Acquired von Willebrand Factor Deficiency in JapanAkitada Ichinose, Tsukasa Osaki, Masayoshi Souri, et al.Seminars in Thrombosis and Hemostasis|July 8, 2022
D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19Jecko Thachil, Emmanuel J Favaloro, Giuseppe LippiSeminars in Thrombosis and Hemostasis|December 1, 2022
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative ReviewTheodore E Warkentin, Andreas GreinacherSeminars in Thrombosis and Hemostasis|January 1, 1985
In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169)J M Walenga, J Fareed, D A HoppensteadtPageof 300